159 related articles for article (PubMed ID: 36895481)
1. Genome-wide identification of A-to-I RNA editing events provides the functional implications in PDAC.
Mei Y; Liang D; Ai B; Wang T; Guo S; Jin G; Yu D
Front Oncol; 2023; 13():1092046. PubMed ID: 36895481
[TBL] [Abstract][Full Text] [Related]
2. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing.
Shen P; Yang T; Chen Q; Yuan H; Wu P; Cai B; Meng L; Huang X; Liu J; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
Mol Cancer; 2021 Mar; 20(1):51. PubMed ID: 33750389
[TBL] [Abstract][Full Text] [Related]
3. ADAR-deficiency perturbs the global splicing landscape in mouse tissues.
Kapoor U; Licht K; Amman F; Jakobi T; Martin D; Dieterich C; Jantsch MF
Genome Res; 2020 Aug; 30(8):1107-1118. PubMed ID: 32727871
[TBL] [Abstract][Full Text] [Related]
4. An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
Ramírez-Moya J; Miliotis C; Baker AR; Gregory RI; Slack FJ; Santisteban P
Mol Cancer; 2021 Sep; 20(1):115. PubMed ID: 34496885
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification and characterization of tissue-specific RNA editing events in D. melanogaster and their potential role in regulating alternative splicing.
Mazloomian A; Meyer IM
RNA Biol; 2015; 12(12):1391-401. PubMed ID: 26512413
[TBL] [Abstract][Full Text] [Related]
6. Global RNA editing identification and characterization during human pluripotent-to-cardiomyocyte differentiation.
Chen J; Liu HF; Qiao LB; Wang FB; Wang L; Lin Y; Liu J
Mol Ther Nucleic Acids; 2021 Dec; 26():879-891. PubMed ID: 34760335
[TBL] [Abstract][Full Text] [Related]
7. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
8. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
[TBL] [Abstract][Full Text] [Related]
9. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract][Full Text] [Related]
10. Identification and Analysis of RNA Editing Events in Ovarian Serous Cystadenoma Using RNA-seq Data.
Wang Y; Song X; Xu T
Curr Gene Ther; 2021; 21(3):258-269. PubMed ID: 33573552
[TBL] [Abstract][Full Text] [Related]
11. RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling.
Shimokawa T; Rahman MF; Tostar U; Sonkoly E; Ståhle M; Pivarcsi A; Palaniswamy R; Zaphiropoulos PG
RNA Biol; 2013 Feb; 10(2):321-33. PubMed ID: 23324600
[TBL] [Abstract][Full Text] [Related]
12. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk.
Tian J; Chen C; Rao M; Zhang M; Lu Z; Cai Y; Ying P; Li B; Wang H; Wang L; Li Y; Huang J; Fan L; Cai X; Ning C; Li Y; Zhang F; Wang W; Jiang Y; Liu Y; Wang M; Li H; Huang C; Yang Z; Chang J; Zhu Y; Yang X; Miao X
Cancer Res; 2022 Jun; 82(11):2084-2096. PubMed ID: 35363263
[TBL] [Abstract][Full Text] [Related]
13. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide detection of RNA editing events during the hair follicles cycle of Tianzhu white yak.
Zhou X; Bao P; Zhang X; Guo X; Liang C; Chu M; Wu X; Yan P
BMC Genomics; 2022 Oct; 23(1):737. PubMed ID: 36316632
[TBL] [Abstract][Full Text] [Related]
15. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
Lu J; Wei S; Lou J; Yin S; Zhou L; Zhang W; Zheng S
Med Sci Monit; 2020 Jul; 26():e925733. PubMed ID: 32706768
[TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker.
Qin JX; Liu X; Wang XL; Wang GY; Liang Q; Dong Y; Pang K; Hao L; Xue L; Zhao Y; Hu ZX; Li R; Lv Q; Chao L; Meng FL; Shi ZD; Han CH
Front Genet; 2022; 13():984279. PubMed ID: 36199571
[No Abstract] [Full Text] [Related]
17. Genome-Wide Characterization of RNA Editing Sites in Primary Gastric Adenocarcinoma through RNA-seq Data Analysis.
Behroozi J; Shahbazi S; Bakhtiarizadeh MR; Mahmoodzadeh H
Int J Genomics; 2020; 2020():6493963. PubMed ID: 33415135
[TBL] [Abstract][Full Text] [Related]
18. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
19. Altered A-to-I RNA editing in human embryogenesis.
Shtrichman R; Germanguz I; Mandel R; Ziskind A; Nahor I; Safran M; Osenberg S; Sherf O; Rechavi G; Itskovitz-Eldor J
PLoS One; 2012; 7(7):e41576. PubMed ID: 22859999
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide identification and analysis of A-to-I RNA editing events in the malignantly transformed cell lines from bronchial epithelial cell line induced by α-particles radiation.
Liu Q; Li H; You L; Li T; Li L; Zhou P; Bo X; Chen H; Chen X; Hu Y
PLoS One; 2019; 14(6):e0213047. PubMed ID: 31158229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
